Yale University

Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.

TitleRisk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.
Publication TypeJournal Article
Year of Publication2011
AuthorsSterling, Timothy R., Bryan Lau, Jinbing Zhang, Aimee Freeman, Ronald J. Bosch, John T. Brooks, Steven G. Deeks, Audrey French, Stephen Gange, Kelly A. Gebo, M. John Gill, Michael A. Horberg, Lisa P. Jacobson, Gregory D. Kirk, Mari M. Kitahata, Marina B. Klein, Jeffrey N. Martin, Benigno Rodriguez, Michael J. Silverberg, James H. Willig, Joseph J. Eron, James J. Goedert, Robert S. Hogg, Amy C. Justice, Rosemary G. McKaig, Sonia Napravnik, Jennifer Thorne, and Richard D. Moore
Corporate AuthorsNorth American AIDS Cohort Collaboration on Research and Design(NA-ACCORD) of the International Epidemiologic Databases to Eval
JournalThe Journal of infectious diseases
Volume204
Issue6
Pagination893-901
Date Published2011 Sep 15
ISSN1537-6613
KeywordsAdult, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Canada, Female, HIV Infections, HIV-1, Humans, Male, Middle Aged, Risk Factors, Tuberculosis, United States
AbstractScreening for tuberculosis prior to highly active antiretroviral therapy (HAART) initiation is not routinely performed in low-incidence settings. Identifying factors associated with developing tuberculosis after HAART initiation could focus screening efforts.
DOI10.1093/infdis/jir421
Alternate JournalJ. Infect. Dis.

External Links